semaglutide and eye blindness Study reveals potential risk for (Ozempic) users Popular weight loss and diabetes

Tufts Now: Dariush Mozaffarian : GLP-1s have captured national attention for their ability to help people achieve significant weight reduction, but successful weight loss requires more than a prescription

The retrospective study tracked patient outcomes over a three-year period, using data collected between 2020 and 2023

How It Works : Tirzepatide activates both GLP-1 and GIP pathways to produce greater weight loss and improve blood sugar and metabolic function

RESULTS Oral semaglutide was superior to placebo in reducing HbA 1c (estimated treatment difference [ETD] 0.5% [95% CI 0.7, 0.3], 0.9% [1.1, 0.7], and 1.2% [1.4, 1.0] for 3, 7, and 14 mg, respectively

There is also growing evidence that the use of GLP-1RAs could lead to broader consumer habit changes such as a reduction in calories consumed and an increase in physical activity and changes in overall population health (e.g

If your doctor thinks you require more, there are doses available in 7.5-mg, 10-mg, 12.5-mg, and 15-mg pens